The cross-reactivity of binding antibodies with different interferon beta formulations used as disease-modifying drugs in multiple sclerosis patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference26 articles.
1. Study, GroupInterferon beta-1b is effective in relapsing-remitting multiple sclerosis.;Neurology,1993
2. PRISM, GroupRandomised double-blind placebo-controlled study of interferon b- 1a in relapsingremitting multiple sclerosis.;Ann Neurol,1996
3. Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS;Kappos;Neurology,2006
4. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG);Jacobs;Ann Neurol,1996
5. MSTreatment optimisation in multiple sclerosis: report of an international consensous meeting.;Eur J Neurol,2004
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy;Journal of Controlled Release;2021-03
2. Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β;Multiple Sclerosis and Related Disorders;2020-04
3. Anti-interferon-beta antibodies in Polish multiple sclerosis patients: prevalence and clinical significance in a long-term prospective study;Neurologia i Neurochirurgia Polska;2018-12-11
4. Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability;International Immunopharmacology;2018-09
5. Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge;Expert Review of Clinical Immunology;2018-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3